Literature DB >> 26936634

Extracellular granzyme K mediates endothelial activation through the cleavage of protease-activated receptor-1.

Mehul Sharma1,2, Yulia Merkulova1,2, Sheetal Raithatha1, Leigh G Parkinson1,2, Yue Shen1,2, Dawn Cooper3, David J Granville1,2.   

Abstract

Granzymes are a family of serine proteases that were once thought to function exclusively as mediators of cytotoxic lymphocyte-induced target cell death. However, non-apoptotic roles for granzymes, including granzyme K (GzK), have been proposed. As recent studies have observed elevated levels of GzK in the plasma of patients diagnosed with clinical sepsis, we hypothesized that extracellular GzK induces a proinflammatory response in endothelial cells. In the present study, extracellular GzK proteolytically activated protease-activated receptor-1 leading to increased interleukin 6 and monocyte chemotactic protein 1 production in endothelial cells. Enhanced expression of intercellular adhesion molecule 1 along with an increased capacity for adherence of THP-1 cells was also observed. Characterization of downstream pathways implicated the mitogen-activated protein kinase p38 pathway for intercellular adhesion molecule 1 expression, and both the p38 and the extracellular signal-regulated protein kinases 1 and 2 pathways in cytokine production. GzK also increased tumour necrosis factor α-induced inflammatory adhesion molecule expression. Furthermore, the physiological inhibitor of GzK, inter-α-inhibitor protein, significantly inhibited GzK activity in vitro. In summary, extracellular GzK promotes a proinflammatory response in endothelial cells.
© 2016 Federation of European Biochemical Societies.

Entities:  

Keywords:  endothelial cells; granzyme K; inflammation; protease-activated receptors; serine proteases

Mesh:

Substances:

Year:  2016        PMID: 26936634     DOI: 10.1111/febs.13699

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  12 in total

1.  Inter-alpha inhibitor proteins attenuate lipopolysaccharide-induced blood-brain barrier disruption and downregulate circulating interleukin 6 in mice.

Authors:  Aric F Logsdon; Michelle A Erickson; Xiaodi Chen; Joseph Qiu; Yow-Pin Lim; Barbara S Stonestreet; William A Banks
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-24       Impact factor: 6.200

2.  Differential Expression of CD8+ T Cell Cytotoxic Effector Molecules in Blood and Gastrointestinal Mucosa in HIV-1 Infection.

Authors:  Brenna E Kiniry; Peter W Hunt; Frederick M Hecht; Ma Somsouk; Steven G Deeks; Barbara L Shacklett
Journal:  J Immunol       Date:  2018-01-19       Impact factor: 5.422

3.  RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation.

Authors:  Jane A C Wilson; Natalie A Prow; Wayne A Schroder; Jonathan J Ellis; Helen E Cumming; Linden J Gearing; Yee Suan Poo; Adam Taylor; Paul J Hertzog; Francesca Di Giallonardo; Linda Hueston; Roger Le Grand; Bing Tang; Thuy T Le; Joy Gardner; Suresh Mahalingam; Pierre Roques; Phillip I Bird; Andreas Suhrbier
Journal:  PLoS Pathog       Date:  2017-02-16       Impact factor: 6.823

4.  Granzyme A inhibition reduces inflammation and increases survival during abdominal sepsis.

Authors:  Marcela Garzón-Tituaña; José L Sierra-Monzón; Laura Comas; Llipsy Santiago; Tatiana Khaliulina-Ushakova; Iratxe Uranga-Murillo; Ariel Ramirez-Labrada; Elena Tapia; Elena Morte-Romea; Sonia Algarate; Ludovic Couty; Eric Camerer; Phillip I Bird; Cristina Seral; Pilar Luque; José R Paño-Pardo; Eva M Galvez; Julián Pardo; Maykel Arias
Journal:  Theranostics       Date:  2021-01-30       Impact factor: 11.556

5.  The role of protease-activated receptor 1 signaling in CD8 T cell effector functions.

Authors:  Hui Chen; Mindy Smith; Jasmin Herz; Tong Li; Rebecca Hasley; Cecile Le Saout; Ziang Zhu; Jie Cheng; Andres Gronda; José A Martina; Pablo M Irusta; Tatiana Karpova; Dorian B McGavern; Marta Catalfamo
Journal:  iScience       Date:  2021-10-30

6.  Biological relevance of Granzymes A and K during E. coli sepsis.

Authors:  Iratxe Uranga-Murillo; Elena Tapia; Marcela Garzón-Tituaña; Ariel Ramirez-Labrada; Llipsy Santiago; Cecilia Pesini; Patricia Esteban; Francisco J Roig; Eva M Galvez; Phillip I Bird; Julián Pardo; Maykel Arias
Journal:  Theranostics       Date:  2021-10-17       Impact factor: 11.556

Review 7.  Granzymes: The Molecular Executors of Immune-Mediated Cytotoxicity.

Authors:  Zachary L Z Hay; Jill E Slansky
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 6.208

Review 8.  Natural Killer Cells: Angels and Devils for Immunotherapy.

Authors:  Beatriz Martín-Antonio; Guillermo Suñe; Lorena Perez-Amill; Maria Castella; Alvaro Urbano-Ispizua
Journal:  Int J Mol Sci       Date:  2017-08-29       Impact factor: 5.923

Review 9.  The Multifaceted Function of Granzymes in Sepsis: Some Facts and a Lot to Discover.

Authors:  Marcela Garzón-Tituaña; Maykel A Arias; José L Sierra-Monzón; Elena Morte-Romea; Llipsy Santiago; Ariel Ramirez-Labrada; Luis Martinez-Lostao; José R Paño-Pardo; Eva M Galvez; Julián Pardo
Journal:  Front Immunol       Date:  2020-06-17       Impact factor: 7.561

10.  Extracellular Granzyme K Modulates Angiogenesis by Regulating Soluble VEGFR1 Release From Endothelial Cells.

Authors:  Shuang Li; Christian G M van Dijk; Jan Meeldijk; Helena M Kok; Isabelle Blommestein; Annick L F Verbakel; Marit Kotte; Roel Broekhuizen; Miangela M Laclé; Roel Goldschmeding; Caroline Cheng; Niels Bovenschen
Journal:  Front Oncol       Date:  2021-06-09       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.